pirfenidone has been researched along with Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, L; Cho, IH; Hyun, BH; Kim, YJ; Lee, CH; Margolin, SB; Park, HS; Park, YH | 1 |
| Furutani, S; Komemushi, S; Margolin, S; Ota, K; Suga, H; Teraoka, S; Yamauchi, S | 1 |
2 other study(ies) available for pirfenidone and Sclerosis
| Article | Year |
|---|---|
Pirfenidone suppressed the development of glomerulosclerosis in the FGS/Kist mouse.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Disease Models, Animal; Female; Fibrosis; Glomerular Filtration Rate; Glomerulonephritis; Kidney; Kidney Diseases; Male; Mice; Proteinuria; Pyridones; Sclerosis; Time Factors | 2003 |
Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Chlorhexidine; Fibrosis; Intestines; Liver; Male; Peritonitis; Pyridones; Rats; Rats, Wistar; Sclerosis | 1995 |